Ivosidenib
Ivosidenib Phase 1 (glioma)
Servier · Phase 1 · Completed · Enrollment 174
| Arm | Reported safety |
|---|---|
| Ivosidenib, non-enhancing glioma | n/r |
A count stays a count. This page does not turn a count into a percent.
Disease Pipeline Tools IDH-mutant glioma
IDH-mutant glioma
Programs, trials, and reported response and survival for IDH-mutant glioma.
Ivosidenib
Servier · Phase 1 · Completed · Enrollment 174
| Arm | Reported safety |
|---|---|
| Ivosidenib, non-enhancing glioma | n/r |
A count stays a count. This page does not turn a count into a percent.